European biotech leaders explore China's role in global life sciences innovation at Paris roundtable

A recent roundtable discussion at our Paris office explored the evolving role of China in the global biotechnology ecosystem and the opportunities it presents for European life sciences companies and investors.

The session focused on how organisations can access Chinese innovation, accelerate clinical development, structure cross-border transactions to maximise value, and navigate the regulatory, intellectual property and geopolitical considerations that increasingly shape China-related deals.

The discussion brought together leading voices from across the biotech and investment landscape.